About   Help   FAQ
Phenotypes Associated with This Genotype
Genotype
MGI:3526398
Allelic
Composition
Plattm1Mlg/Plattm1Mlg
Genetic
Background
B6.Cg-Plattm1Mlg
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Plattm1Mlg mutation (5 available); any Plat mutation (57 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
behavior/neurological
N
• homozygotes show normal footshock sensitivity thresholds relative to wild-type mice
• homozygotes show no significant differences in the antinociceptive effect of morphine or development of its tolerance relative to wild-type mice
• notably, homozygotes display a significant reduction in morphine-induced hyperlocomotion relative to wild-type
• the defect of morphine-induced hyperlocomotion is reversed by exogenous administration of tPA or plasmin into the nucleus accumbens (Nacc)
• homozygotes display poor active avoidance behavior relative to wild-type mice
• homozygotes display a significant reduction in morphine-induced conditioned place preference
• homozygotes display poor contextual fear conditioning behavior relative to wild-type mice, indicating impaired hippocampal function
• homozygotes display enhanced cue fear conditioning behavior relative to wild-type mice
• relative to wild-type, mutant mice exhibit a 28% reduction in both the rate and extent of learning a complex motor paradigm of irregular peg running, indicating impaired cerebellar motor learning
• homozygotes display no habitation of object exploration relative to wild-type mice
• homozygotes show no reactivity to spatial change (measured as renewed exploration of displaced objects) relative to wild-type mice
• after up to 3 weeks of daily restraint, homozygotes exhibit absence of stress-induced anxiety in the elevated-plus maze; in wild-type, acute stress resuls in a decrease in open arm entries, with 21 days of daily restraint leading to some habituation (J:81694)
• in response to a low or middle dose of corticotropin-releasing factor (CRF), homozygotes exhibit reduced anxiety (lower number of open arm entries) in the elevated plus-maze, with an increased number of head dips (increased exploration) relative to wild-type (J:94733)
• in response to a high dose of CRF, homozygotes fail to explore the open arms but display a similar number of closed arms entries relative to wild-type mice, indicating normal locomotor activity (J:94733)
• in an empty open field, homozygotes show normal horizontal activity but significantly reduced rearing activity relative to wild-type

homeostasis/metabolism
• after a 30-min restraint stress, homozygotes exhibit a 30% increase in corticosterone levels relative to wil-type (J:81694)
• unlike wild-type mice, corticosterone levels in mutant mice do not return to pre-stress levels after a 90-min recovery period (J:81694)
• homozygotes show normal up-regulation of corticosterone in response to CRF but sustain elevation of corticosterone level during recovery (J:94733)
• in a model of pulmonary microembolism, wild-type mice are able to clear 125I-microemboli rapidly with complete lysis by 5 hours; in contrast, mutants remain unable to lyse pulmonary microemboli throughout the 5-hr experimental period
• homozygotes exhibit loss of morphine-induced dopamine release in the nucleus accumbens (Nacc)
• the defect of morphine-induced dopamine release is reversed by exogenous administration of tPA or plasmin into the Nacc but not into the ventral tegmental area (VTA)
• in a model of collagen-induced arthritis, 60% of mutant mice have 3 or 4 affected limbs compared with only 18% of wild-type mice
• in arthritic mutants, 45% of affected individual limbs display severe swelling and/or rigidity compared with only 19% from wild-type
• there are no differences in the degree of swelling (i.e. paw thickness) between limbs from mutant and wild-type mice with the same clinical score
• in a model of collagen-induced arthritis, severely affected joints from homozygotes display diffuse fibrin(ogen) deposition relative to wild-type
• within arthritic joints, higher fibrin levels appear to correlate with increased disease severity
• in a model of collagen-induced arthritis, arthritic homozygotes exhibit a significant increase in interleukin-1beta levels in the synovium relative to wild-type
• in a model of collagen-induced arthritis, ankle joint washouts from arthritic homozygotes exhibit a significant increase in TNF levels relative to wild-type

immune system
• in a model of collagen-induced arthritis, severely affected joints from homozygotes display diffuse fibrin(ogen) deposition relative to wild-type
• within arthritic joints, higher fibrin levels appear to correlate with increased disease severity
• in a model of collagen-induced arthritis, arthritic homozygotes exhibit a significant increase in interleukin-1beta levels in the synovium relative to wild-type
• in a model of collagen-induced arthritis, ankle joint washouts from arthritic homozygotes exhibit a significant increase in TNF levels relative to wild-type
• in a model of collagen-induced arthritis, homozygotes develop significant joint inflammation and joint destruction relative to wild-type mice
• severely affected joints from arthritic homozygotes exhibit massive cell infiltration and higher proteoglycan depletion than wild-type mice
• in a model of collagen-induced arthritis, homozygotes develop a significantly more severe arthritis than wild-type mice
• 95% of mutant mice develop arthritis compared with 68% of wild-type mice; no difference in the day of disease onset is observed
• severely affected joints from arthritic homozygotes exhibit higher cartilage damage and bone erosions than wild-type mice

muscle
N
• in response to glycerol-induced injury, homozygotes exhibit normal skeletal muscle regeneration after 5 days; regeneration is complete after 9 days
• at 7 days after injury, most injured fibers regenerate into groups of centrally nucleated myotubes, indicating advanced regeneration; only few necrotic fibers are observed
• at 20 days after injury, virtually no signs of muscle injury are detected, except for centrally located myonuclei inside the regenerated fibers

skeleton
• in a model of collagen-induced arthritis, 60% of mutant mice have 3 or 4 affected limbs compared with only 18% of wild-type mice
• in arthritic mutants, 45% of affected individual limbs display severe swelling and/or rigidity compared with only 19% from wild-type
• there are no differences in the degree of swelling (i.e. paw thickness) between limbs from mutant and wild-type mice with the same clinical score
• in a model of collagen-induced arthritis, homozygotes develop significant joint inflammation and joint destruction relative to wild-type mice
• severely affected joints from arthritic homozygotes exhibit massive cell infiltration and higher proteoglycan depletion than wild-type mice
• in a model of collagen-induced arthritis, homozygotes develop a significantly more severe arthritis than wild-type mice
• 95% of mutant mice develop arthritis compared with 68% of wild-type mice; no difference in the day of disease onset is observed
• severely affected joints from arthritic homozygotes exhibit higher cartilage damage and bone erosions than wild-type mice

nervous system
• after restraint, homozygotes show reduced neuronal remodeling in the medial amygdala, with absence of stress-induced ERK1/2 phosphorylation at all time points tested (J:81694)
• in response to CRF, homozygotes exhibit attenuated expression of Fos (an indicator of neuronal activation) in the central and medial amygdala but show normal Fos responses in paraventricular nuclei (J:94733)
• in response to tetanic stimulation, hippocampal CA1 slices from mutant mice show a significant reduction in the late phase of LTP relative to wild-type
• notably, a slight but significant reduction of the early phase of hippocampal LTP is also observed
• in response to tetanic stimulation of corticostriatal fibers, homozygotes display absence of LTD in a significant portion of striatal neurons


Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
06/16/2026
MGI 6.24
The Jackson Laboratory